Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 15,985-15,996 of 23,847
Drug study icon
TerminatedNCT01504659

Intranasal Ketamine In the Treatment of Pediatric Bipolarity

This study exists to understand whether ketamine treatment is both safe enough and useful enough to take further. Researchers are trying to understand whether ketamine treatment can better prevent setbacks and support longer-term stability.

Multiple locations, including Not Predetermined
BipolarityDrugA study involving a medication or substance.From 6 Years to 12 Years
Countries
United States
Sponsor
Juvenile Bipolar Research Foundation
Condition
Bipolarity
Drug study icon
CompletedNCT03878316

Intranasal Oxytocin for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Los Angeles
AddictionDrugOver 18 Years
Countries
United States
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition
Addiction
Drug study icon
CompletedNCT01281969

Intravenous Immunoglobulin for PANDAS

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
OCD, AnxietyDrugFrom 4 Years to 13 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
OCD, Anxiety
Drug study icon
TerminatedNCT01371110

Intravenous Ketamine in the Treatment of OCD

This summary needs review. Please check the official study record and contact the research team for details.

In New York
OCDDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
Wayne Goodman MD
Condition
OCD
Behavioral study icon
CompletedNCT05031611

Intuitive Eating for Disordered Eating

This summary needs review. Please check the official study record and contact the research team for details.

In The Bronx
Eating disordersBehavioralFrom 18 Years to 30 Years
Countries
United States
Sponsor
Yeshiva University
Condition
Eating disorders
Behavioral study icon
CompletedNCT02048241

Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder

This study exists to see whether smoking support or smoking-related treatment can play a useful role in care. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

In New York
ADHDBehavioralFrom 6 Years to 12 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
ADHD
Drug study icon
CompletedNCT01177306

Inuniv and Working Memory

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

In Cary
ADHDDrugFrom 8 Years to 12 Years
Countries
United States
Sponsor
Lori A. Schweickert, MD
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.